BoTox Into the Sternocleidomastoid Muscles (SCM)

PHASE4RecruitingINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

May 14, 2025

Primary Completion Date

March 31, 2026

Study Completion Date

March 31, 2026

Conditions
Neck Muscle Issue
Interventions
DRUG

prabotulinumtoxinA-xvfs

Each participant will receive 60 units (U) of prabotulinumtoxinA-xvfs into each SCM for a total of 120 U. Participants will return in 2 weeks to determine if any touch-up injection is needed.

Trial Locations (1)

02459

RECRUITING

The Spiegel Center, Newton

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Evolus, Inc.

INDUSTRY

lead

Boston Medical Center

OTHER

NCT06903975 - BoTox Into the Sternocleidomastoid Muscles (SCM) | Biotech Hunter | Biotech Hunter